Abstract:Background Keloid has brought great trouble to people and currently has no uniformly successful treatment. It is urgent to find new targets to effectively prevent the progress of keloid. The current research mainly identifies the differentially expressed genes (DEGs) in keloid through high-throughput sequencing technology and bioinformatics analysis technology, to screen new therapeutic targets and potential biomarkers. However, due to the different samples, different control groups, and small sample sizes, the sequencing results obtained from different studies are quite different and lack reliability. It is necessary to analyze the existing datasets in a reasonable way. Methods Datasets about keloid were filtered in Gene Expression Omnibus (GEO) and ArrayExpress databases according to the inclusion and exclusion criteria. The discovery datasets were used for summarizing significant DEGs, and the validation datasets were to validate the mRNA and miRNA expression levels. The Encyclopedia of RNA Interactomes (ENCORI) online platform was used to predict the interactions between miRNAs and their target mRNAs. Protein-protein interaction network (PPI network) analysis and functional enrichment analysis were conducted. miRNA-mRNA network was established by Cytoscape software and verified in keloid tissue (n = 8) by RT-qPCR. miR-29a-3p mimic and inhibitor were transfected into keloid fibroblasts (KFs) to preliminary verify its targets, the prognostic value of which was estimated by the receiver operating characteristic (ROC) curve. Results A total of 6 datasets involving 20 patients were included. 15 miRNAs and 12 target mRNAs were identified as potential biomarkers for keloid patients. The RT-qPCR results showed that miR-29a-3p, miR-92a-3p, and miR-143-3p were downregulated, and all their target mRNAs were upregulated in keloid tissue (P < 0.05). The expression of COL1A1, COL1A2, COL3A1, COL5A1, and COL5A2 decreased when miR-29a-3p was overexpressed but increased when miR-29a-3p was knocked down (P < 0.05). And these genes had a good performance in the diagnosis of keloid, especially when using keloid nonlesional skin or normal scar tissues as controls. Conclusion The miRNA-mRNA network, especially miR-29a-3p and its targets, may provide insights into the underlying pathogenesis of keloid and serve as potential biomarkers for keloid treatment.

miRNA Expression and Key miRNA Screening in Acute Stage of Skin Expansion

Differentially Expressed Mirnas in Acute Wound Healing of the Skin

Coexpression analysis of angiogenesis, proliferation, apoptosis, autophagy and SHH pathway genes involved in skin expansion

Comprehensive analysis of skin growth-related hub genes and microenvironment characterization in a mouse expanded skin model

A preliminary study of differentially expressed genes in expanded skin and normal skin: implications for adult skin regeneration

Differentially Expressed Mirnas Profiles in Mid- and Late-Gestational Fetal Skin and Biological Functions

Analysis of the Expression Profile of Mirnas Related to Skin Photoaging in the GEO Database

Microrna Profiling in Mid- and Late-Gestational Fetal Skin: Implication for Scarless Wound Healing

miRNA delivery for skin wound healing.

133 Distinctive Mirna Expression Profiles in Tissue and Serum of Primary Extramammary Pagets Disease

MicroRNA Profile Analysis on Duck Feather Follicle and Skin with High-Throughput Sequencing Technology.

Comparative Study of Microrna Profiling in Keloid Fibroblast and Annotation of Differential Expressed Micrornas.

A Panel Of Mirnas As Prognostic Indicators For Clinical Outcome Of Skin Cutaneous Melanoma

Advances of the Effect of miRNA in Skin Tissue

Single-cell profiling and functional screening reveal crucial roles for lncRNAs in the epidermal re-epithelialization of human acute wounds

[Differential Expression Profile of Microrna Between Hyperplastic Scar and Normal Skin].

Differential Expression of Micrornas and Their Regulatory Networks in Skin Tissue of Liaoning Cashmere Goat During Hair Follicle Cycles

Identification of novel candidate genes and predicted miRNAs in atopic dermatitis patients by bioinformatic methods

MicroRNA profiling in denatured dermis of deep burn patients.

Differential Expression of Mir-202 and Validation of Predicted Target Genes in the Skin Tissue of C57BL/6 Black Mice and BALB/c White Mice

Identifying Mirnas Associated with the Progression of Keloid Through Mrna-Mirna Network Analysis and Validating the Targets of Mir-29A-3p in Keloid Fibroblasts